Detalhe da pesquisa
1.
Lyophilization Based Isolation of Exosomes.
Int J Mol Sci
; 24(13)2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445655
2.
AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.
BMC Cancer
; 21(1): 713, 2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140003
3.
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.
Ann Hematol
; 100(8): 2023-2029, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110462
4.
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.
Blood
; 131(3): 311-322, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122757
5.
The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
PLoS Genet
; 11(4): e1005144, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25919613
6.
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I.
BMC Cancer
; 12: 411, 2012 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22985168
7.
Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway.
Neoplasia
; 23(9): 1016-1027, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403880
8.
BCR: a new target in resistance mediated by BCR/ABL-315I?
Genes Cancer
; 7(1-2): 36-46, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27014420
9.
STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML.
Genes Cancer
; 5(11-12): 378-92, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25568664
10.
Seroprevalence of cytomegalovirus, herpes simplex virus and rubella virus among pregnant women in KPK province of Pakistan.
J Infect Dev Ctries
; 8(3): 389-90, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619273